Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-16-100066
Filing Date
2016-02-25
Accepted
2016-02-25 17:19:04
Documents
73
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a15-23224_110k.htm 10-K 1664596
2 EX-10.8 a15-23224_1ex10d8.htm EX-10.8 84206
3 EX-10.10 a15-23224_1ex10d10.htm EX-10.10 76086
4 EX-10.11 a15-23224_1ex10d11.htm EX-10.11 17537
5 EX-10.12 a15-23224_1ex10d12.htm EX-10.12 19356
6 EX-10.13 a15-23224_1ex10d13.htm EX-10.13 19371
7 EX-10.14 a15-23224_1ex10d14.htm EX-10.14 16557
8 EX-21 a15-23224_1ex21.htm EX-21 1088
9 EX-23 a15-23224_1ex23.htm EX-23 3763
10 EX-31.1 a15-23224_1ex31d1.htm EX-31.1 10028
11 EX-31.2 a15-23224_1ex31d2.htm EX-31.2 9919
12 EX-32.1 a15-23224_1ex32d1.htm EX-32.1 4946
13 EX-32.2 a15-23224_1ex32d2.htm EX-32.2 4978
20 GRAPHIC g232241boi001.gif GRAPHIC 14567
  Complete submission text file 0001104659-16-100066.txt   7912195

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE DOCUMENT sgyp-20151231.xml EX-101.INS 1840489
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20151231.xsd EX-101.SCH 55924
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20151231_cal.xml EX-101.CAL 53127
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20151231_def.xml EX-101.DEF 216414
18 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20151231_lab.xml EX-101.LAB 495515
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20151231_pre.xml EX-101.PRE 375661
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35268 | Film No.: 161456950
SIC: 2834 Pharmaceutical Preparations